# Tocilizumab in the treatment of IgG4-related disease involving the carotid artery-case report and literature review

**Authors:** Xiaoxu Ding, Juan Tao, Cheng Xu, Yongmei Han

PMC · DOI: 10.3389/fimmu.2026.1734761 · 2026-03-06

## TL;DR

This paper reports a rare case of IgG4-related disease affecting the carotid artery and vagus nerve, successfully treated with tocilizumab after other therapies failed.

## Contribution

The study presents a rare case of IgG4-RD involving the carotid artery and vagus nerve, highlighting the effectiveness of tocilizumab in treatment-resistant cases.

## Key findings

- IgG4-related disease involving the carotid artery and vagus nerve is exceptionally rare.
- Tocilizumab achieved sustained remission in a patient unresponsive to glucocorticoids and methotrexate.

## Abstract

IgG4-related disease (IgG4-RD) is an autoimmune disorder characterized by fibroinflammatory infiltration of affected organs. This systemic condition can involve multiple organs, including the pancreas, bile ducts, salivary glands, kidneys and lungs. However, IgG4-related disease demonstrates substantial heterogeneity and frequently involves atypical anatomical sites, leading to frequent clinical misdiagnosis. We report a rare case of IgG4-RD involving the carotid artery and vagus nerve, presenting with hoarseness and syncope. Diagnosis was confirmed via contrast-enhanced neck MRI and carotid artery biopsy. The patient exhibited poor response to glucocorticoids and methotrexate but achieved sustained remission following combination therapy with tocilizumab. A literature review revealed that isolated involvement of the carotid artery and vagus nerve in IgG4-RD is exceptionally rare.

## Linked entities

- **Chemicals:** methotrexate (PubChem CID 4112)
- **Diseases:** IgG4-related disease (MONDO:0017287), autoimmune disorder (MONDO:0007179)

## Full-text entities

- **Diseases:** syncope (MESH:D013575), hoarseness (MESH:D006685), autoimmune disorder (MESH:D001327), IgG4-RD (MESH:D000077733)
- **Chemicals:** Tocilizumab (MESH:C502936), methotrexate (MESH:D008727)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC13019729/full.md

---
Source: https://tomesphere.com/paper/PMC13019729